Tolvaptan add-on therapy and its effects on efficacy parameters and outcomes in patients hospitalized with heart failure.
Indian Heart J
; 74(1): 40-44, 2022.
Article
in En
| MEDLINE
| ID: mdl-34919966
Full text:
1
Collection:
01-internacional
Database:
MEDLINE
Main subject:
Antidiuretic Hormone Receptor Antagonists
/
Tolvaptan
/
Heart Failure
Type of study:
Clinical_trials
/
Systematic_reviews
Limits:
Humans
Language:
En
Journal:
Indian Heart J
Year:
2022
Document type:
Article